Latest Strategy Changes News

Global Lithium’s proposed acquisition of the Nova Operation from IGO has become unconditional after the ACCC waived its notification requirement. Completion is still pending the shutdown and final shipment timetable, with the transaction not yet completed.

PMET Resources says Koch Technology Solutions has demonstrated a more selective pathway for turning Shaakichiuwaanaan pollucite concentrate into multiple high-purity caesium chemicals. The result is promising, but the commercial case still depends on larger-scale testing, marketable samples and a planned economic assessment.

Tuas Limited (ASX:TUA) delivered a sharp FY2026 earnings lift as Simba’s mobile and broadband subscriber base expanded, with statutory profit rising 277% to S$26.0 million. The result arrives with the M1 acquisition abandoned, S$364.5 million raised but not yet allocated, and an unresolved Singapore spectrum investigation.

Dimensional’s five ASX-quoted trusts all produced positive total returns in the year to 30 June 2026, led by the Global Value Trust at 27.812%. The audited report also records lower management fees for three global strategies, although the figures remain a look back rather than a forecast.

Ovanti’s Malaysian subsidiary iSentric has secured a RM5.17 million High Court judgment, worth about A$1.78 million, against two companies tied to historical transactions. The company is also preparing further claims against former directors, officers and auditors, with estimated outstanding claims of up to A$20 million, although no recovery is guaranteed.

Nufarm expects FY26 underlying EBITDA to rise about 25% at the midpoint of its $370 million to $380 million range, while leverage falls from 2.7 times to approximately 2.0 times. The improvement comes alongside a sweeping cost-reduction program, but restructuring charges of up to $110 million post tax remain in the numbers.

Astron Limited (ASX:ATR) says its Donald rare earths and mineral sands project is construction-ready, with a $759 million Phase 1 pre-tax NPV and first production targeted for 2028. The unresolved question is whether debt financing can convert the project’s strong study economics into a final investment decision.

Firebrick Pharma has received a $293,000 R&D Tax Incentive payment linked to $673,000 of eligible development spending on new Nasodine products. The non-dilutive cash arrives as the company broadens its product range and pursues approvals in additional markets.

MyEco Group is seeking up to $1.5 million through a discounted, non-underwritten share purchase plan to expand council and waste management sales, retail distribution and its eco-home range. The final issue price and amount raised remain uncertain, with the company retaining the option to scale up the offer or pursue a follow-on placement.

Clover Corporation has delivered record FY26 revenue of $97.4 million and a 50% lift in attributable profit, while raising its fully franked final dividend to 1.25 cents per share. The result comes alongside a planned chair transition, with Ian Glasson set to replace retiring chair Rupert Harrington after the 2026 AGM.

Ballard Mining has lifted the Mt Ida Gold Project’s global Mineral Resource Estimate by 56% to 1.84 million ounces, led by a larger Baldock deposit and new regional resources. The increase gives the planned feasibility study a much larger technical base, although most of the resource remains Inferred and is not yet an Ore Reserve.

Medallion Metals has shifted from project preparation to execution, with Ravensthorpe fully permitted, Forrestania acquired and Cosmic Boy refurbishment underway. The transition is funded by cash, equity and a US$50 million Trafigura facility, but production delivery and rehabilitation liabilities remain substantial tests.